Development and validation of imaging-free myocardial fibrosis prediction models, association with outcomes, and sample size estimation for phase 3 trials
View ORCID ProfileNicholas Black, View ORCID ProfileJoshua Bradley, Gavin Lewis, Jakub Lagan, Christopher Orsborne, View ORCID ProfileFardad Soltani, View ORCID ProfileJohn P. Farrant, Theresa McDonagh, Matthias Schmitt, João L Cavalcante, Martin Ugander, Javed Butler, Mark C. Petrie, Christopher A. Miller, Erik B. Schelbert
doi: https://doi.org/10.1101/2024.02.07.24302443
Nicholas Black
aDivision of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
bManchester University NHS Foundation Trust, Manchester, UK
BM BChJoshua Bradley
aDivision of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
bManchester University NHS Foundation Trust, Manchester, UK
PhDGavin Lewis
cLiverpool University Hospitals NHS Foundation Trust, Royal Liverpool University Hospital, Mount Vernon St, Liverpool L7 8YE
PhDJakub Lagan
cLiverpool University Hospitals NHS Foundation Trust, Royal Liverpool University Hospital, Mount Vernon St, Liverpool L7 8YE
PhDChristopher Orsborne
aDivision of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
bManchester University NHS Foundation Trust, Manchester, UK
MBChBFardad Soltani
aDivision of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
bManchester University NHS Foundation Trust, Manchester, UK
MBChBJohn P. Farrant
aDivision of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
bManchester University NHS Foundation Trust, Manchester, UK
MBChBTheresa McDonagh
dKing’s College Hospital, London, UK
MDMatthias Schmitt
aDivision of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
bManchester University NHS Foundation Trust, Manchester, UK
PhDJoão L Cavalcante
eAllina Health Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
MDMartin Ugander
fKolling Institute, Royal North Shore Hospital, and University of Sydney, Sydney, Australia
gDepartment of Clinical Physiology, Karolinska University Hospital, and Karolinska Institutet, Stockholm, Sweden
MD, PhDJaved Butler
hBaylor Scott and White Research Institute, Dallas, Texas, USA
MDMark C. Petrie
iSchool of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK
MDChristopher A. Miller
aDivision of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
bManchester University NHS Foundation Trust, Manchester, UK
PhDErik B. Schelbert
eAllina Health Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
jAllina Health Minneapolis Heart Institute, United Hospital, Saint Paul, Minnesota, USA
MD, MS
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Posted February 07, 2024.
Development and validation of imaging-free myocardial fibrosis prediction models, association with outcomes, and sample size estimation for phase 3 trials
Nicholas Black, Joshua Bradley, Gavin Lewis, Jakub Lagan, Christopher Orsborne, Fardad Soltani, John P. Farrant, Theresa McDonagh, Matthias Schmitt, João L Cavalcante, Martin Ugander, Javed Butler, Mark C. Petrie, Christopher A. Miller, Erik B. Schelbert
medRxiv 2024.02.07.24302443; doi: https://doi.org/10.1101/2024.02.07.24302443
Development and validation of imaging-free myocardial fibrosis prediction models, association with outcomes, and sample size estimation for phase 3 trials
Nicholas Black, Joshua Bradley, Gavin Lewis, Jakub Lagan, Christopher Orsborne, Fardad Soltani, John P. Farrant, Theresa McDonagh, Matthias Schmitt, João L Cavalcante, Martin Ugander, Javed Butler, Mark C. Petrie, Christopher A. Miller, Erik B. Schelbert
medRxiv 2024.02.07.24302443; doi: https://doi.org/10.1101/2024.02.07.24302443
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)